Valuation: SpineGuard

Market Cap 8.72M 10.07M 8.13M 7.48M 14.12M 958M 14.28M 95.55M 37.5M 479M 37.82M 36.99M 1.59B P/E 2024
-3.63x
P/E 2025 -3.37x
Enterprise Value 8.46M 9.76M 7.88M 7.25M 13.69M 928M 13.84M 92.64M 36.36M 465M 36.67M 35.86M 1.54B EV / Sales 2024
2.94x
EV / Sales 2025 2.33x
Free-Float
97.68%
Yield 2024 *
-
Yield 2025 -
1 day-6.57%
1 week+3.95%
Current month+4.33%
1 month+3.95%
3 months-14.06%
6 months-23.05%
Current year-14.06%
1 week 0.08
Extreme 0.0812
0.1
1 month 0.08
Extreme 0.075
0.1
Current year 0.08
Extreme 0.075
0.14
1 year 0.08
Extreme 0.075
0.3
3 years 0.08
Extreme 0.075
0.5
5 years 0.08
Extreme 0.075
1.77
10 years 0.08
Extreme 0.075
5.49
Manager TitleAgeSince
Chief Executive Officer - 14/02/2020
Director of Finance/CFO - 31/12/2008
Chief Tech/Sci/R&D Officer - 31/08/2019
Director TitleAgeSince
Director/Board Member - 15/01/2009
Director/Board Member - 01/07/2009
Chairman - 28/02/2018
Change 5-day change 1-year change 3-year change Capi.($)
-6.57%+3.95%-22.50%-81.01% 10.07M
-0.31%+0.96%+34.61%+28.07% 12.73B
+0.13%+1.14%+24.73%+23.54% 6.84B
+0.60%+1.05%+52.79%+27.06% 6.13B
-2.26%+0.87% - - 5.21B
-0.48%-1.62%-24.01%+39.21% 4.49B
-0.86%-0.51%-21.63%-19.05% 4.08B
-1.35%+5.59%+40.42%-43.78% 1.87B
-0.34%-3.73%-16.24%+204.10% 1.78B
-0.63%+4.44%+59.04%-2.80% 1.66B
Average -1.20%+2.02%+14.14%+19.48% 4.48B
Weighted average by Cap. -0.46%+0.29%+22.27%+26.73%

Financials

2024 2025
Net sales 4.65M 5.37M 4.33M 3.99M 7.52M 510M 7.61M 50.92M 19.98M 255M 20.16M 19.71M 846M 3.76M 4.34M 3.5M 3.22M 6.08M 413M 6.15M 41.16M 16.15M 206M 16.29M 15.93M 684M
Net income -3.08M -3.56M -2.87M -2.64M -4.99M -338M -5.04M -33.76M -13.25M -169M -13.36M -13.07M -561M -2.07M -2.39M -1.93M -1.77M -3.35M -227M -3.38M -22.65M -8.89M -114M -8.97M -8.77M -376M
Net Debt 1.82M 2.1M 1.7M 1.56M 2.94M 200M 2.98M 19.92M 7.82M 99.9M 7.89M 7.71M 331M -265K -306K -247K -228K -430K -29.13M -434K -2.91M -1.14M -14.58M -1.15M -1.13M -48.28M
Logo SpineGuard
SpineGuard specializes in the design, development, and marketing of medical devices intended to improve the safety of spinal surgery. The group is developing DSG® digital technology for real-time surgical guidance without X-rays to improve the safety and simplify the placement of bone implants, pedicle screws, and "smart" drills. SpineGuard is extending the applications of its DSG® technology to anterior scoliosis treatment, sacroiliac joint fusion, and dental implantology.
Employees
13
Date Price Change Volume
06/08/26 0.0868 -6.57% 440,172
05/08/26 €0.0929 +8.91% 551,304
04/08/26 €0.0853 -5.64% 1,022,174
03/08/26 €0.0904 +8.65% 1,083,712
31/07/26 €0.0832 -0.36% 82,973
  1. Stock Market
  2. Stocks
  3. ALSGD Stock